Roche Announces Interim Results from a Phase III ATLAS Study
- Details
- Category: Roche
![Roche Roche](http://www.worldpharmanews.com/images/stories/logo/roche.gif)
Lipitor Significantly Reduced hsCRP Levels in Patients with Stable Coronary Artery Disease
- Details
- Category: Pfizer
![Pfizer Inc Pfizer Inc](http://www.worldpharmanews.com/images/stories/logo/pfizer_b.gif)
Novartis increases dividend by 25% based on strong 2008 results
- Details
- Category: Novartis
![Novartis Novartis](http://www.worldpharmanews.com/images/stories/logo/novartis_b.gif)
Pfizer Discontinues Global Phase III Trial of Axitinib
- Details
- Category: Pfizer
![Pfizer Inc Pfizer Inc](http://www.worldpharmanews.com/images/stories/logo/pfizer_b.gif)
AstraZeneca PLC Fourth Quarter and Full Year Results 2008
- Details
- Category: AstraZeneca
![AstraZeneca AstraZeneca](http://www.worldpharmanews.com/images/stories/logo/astrazeneca_b.gif)
Strong Fourth Quarter Supports Excellent 2008 for Bristol-Myers Squibb
- Details
- Category: Bristol-Myers Squibb
![Bristol-Myers Squibb Bristol-Myers Squibb](http://www.worldpharmanews.com/images/stories/logo/bms.gif)
GSK to drive growth in emerging markets with acquisition of UCB products
- Details
- Category: GlaxoSmithKline
![GlaxoSmithKline GlaxoSmithKline](http://www.worldpharmanews.com/images/stories/logo/gsk.gif)
More Pharma News ...
- Pfizer to Acquire Wyeth, Creating the World's Premier Biopharmaceutical Company
- Novartis launches Extavia®, the standard-of-care for relapsing forms of multiple sclerosis
- Foundation-laying ceremony for new R&D building at Roche Basel
- Amgen's Breakaway from Cancer Initiative Expands to Help Cancer Patients
- Four innovative Novartis medicines approved in Japan
- Abbott Reports Double-Digit Sales and Earnings Growth in Fourth Quarter
- Johnson & Johnson Reports Full-Year and Fourth-Quarter 2008 Results